Skip to content
Screener

Interest Expense at other companies

BK
BKBK
$4.45B-10.3%
Veradermics logo
VeradermicsMANE
$0-100%
Dollar General logo
Dollar GeneralDG
-$47.24M+26.9%
Target logo
TargetTGT
$117M+0.9%
Barnes Group logo
Barnes GroupB
$19.57M-14.1%
Northern Trust logo
Northern TrustNTRS
$1.58B+0.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1.04B+31.8%
Enterprise value$977.87M
P/S359.8×

Profitability

See full
Operating margin-6,129%
Net margin-5,934%
FCF margin-5,203.9%

Returns & leverage

See full
Return on equity-8,434.8%
Debt / equity0.1×
Current ratio11.4×

Where this comes from

Reported directly by Odyssey Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's interest expense?
Odyssey Therapeutics (ODTX) reported interest expense of $20K in Q2 2026.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Odyssey Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude